Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures ...
Recent advancements in liquid biopsies have demonstrated the potential of cfDNA as a universal, minimally invasive sample type in cancer prognosis, diagnosis, and prenatal testing 1. In parallel, the ...
A key obstacle in isolating cfDNA is the intricate, labor-intensive manual process required by existing protocols to extract it for downstream processing. This article introduces a unique automated ...
Proximity ligation assay (PLA) to identify HER2-negative breast carcinomas responding in HER-3 targeting agents. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Cell-free DNA (cfDNA) is a key analyte for liquid biopsy samples. Due to extremely low concentration and high degree of fragmentation, the extraction of cfDNA is technically challenging. Here, the ...
The much-touted arrival of "precision medicine" promises tailored technologies that help individuals and may also reduce health care costs. New research shows how pregnancy screening can meet both of ...
MANCHESTER, England & SINGAPORE--(BUSINESS WIRE)--Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today launched the Yourgene ® MagBench™ Automated ...
New England Biolabs has released the Monarch ® Mag Cell-free DNA (cfDNA) Extraction Kit, a bead-based method designed for scalable and reproducible isolation of low abundance cfDNA from plasma, serum, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results